Healthy adults
Conditions
Interventions
Daily ingestion of 82 g the tuna dark muscle hamburger steak contained color-faded laver for 12 weeks.
Daily ingestion of 67 g beef meat and Okara hamburger steak for 12 weeks.
Sponsors
Hokkaido Information University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Subjects who fully understand significance, content and purpose of this study and who agree to participate in this study with a written informed consent. 2.Subjects whose BMI is >=23 kg/m2 and <30 kg/m2.
Exclusion criteria
Exclusion criteria: 1.Subjects who are under physician's advice, treatment, and/or medication for obese, dyslipidemia and/or diabetes. 2.Subjects whose postprandial blood glucose is >=200 mg/dl and/or HbA1c >=6.5%. 3.Pacemaker or defibrillator users. 4.Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities. 5.Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 6.Subjects with unusually high and/or low blood pressure and/or abnormal hematological data. 7.Subjects with severe anemia. 8.Pre- or post-menopausal women complaining of obvious physical changes. 9.Subjects who are at risk of having allergic reactions to drugs or foods especially based on fish, seaweed, beef, soybean, shrimp, crab, wheat, chicken, or milk. 10.Subjects who regularly take medicine, functional foods, and/or supplements which would affect BW and BFP. 11.Subjects who regularly take medicine, functional foods, and/or supplements which would affect blood lipid metabolism. 12.Subjects who regularly take medicine, functional foods, and/or supplements which would affect glucose metabolism. 13.Alcohol addicts or subjects with eating disordered lifestyle. 14.Subjects who donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks (men and women), or blood components within 2 weeks (men and women), prior to the current study. 15.Pregnant or lactating women or women who expect to be pregnant during this study. 16.Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study. 17.Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visceral fat area at 12 weeks after beginning the ingestion of test food. | — |
Secondary
| Measure | Time frame |
|---|---|
| total fat area, subcutaneous fat area, fasting blood glucose, HbA1c, fasting insulin, HOMA-IR, blood glucose and insulin after OGTT, body weight, body mass index, body fat rate, muscle mass, abdominal circumference, TBARS, total selenium, selenoneine, total mercury, selenoprotein P, TMAO, VAS questionnaire assessed condition of gastrointestinal tract | — |
Countries
Japan
Contacts
Public ContactJun NISHIHIRA
Hokkaido Information University Health Information Science Center
Outcome results
None listed